2023 Chinese guideline for lipid management

2023 Chinese guideline for lipid management

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for ASCVD. Considering the increasing burden of ASCVD, lipid management is of the utmost importance. In rec...

Full description

Bibliographic Details
Main Authors: Jian-Jun Li, Shui-Ping Zhao, Dong Zhao, Guo-Ping Lu, Dao-Quan Peng, Jing Liu, Zhen-Yue Chen, Yuan-Lin Guo, Na-Qiong Wu, Sheng-Kai Yan, Zeng-Wu Wang, Run-Lin Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
atherosclerosis
cardiovascular disease
lipid
management
statin
combined therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1190934/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1190934/full

Similar Items